Huanwei Chen

1.1k total citations
37 papers, 622 citations indexed

About

Huanwei Chen is a scholar working on Hepatology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Huanwei Chen has authored 37 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hepatology, 13 papers in Surgery and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Huanwei Chen's work include Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Cancer Mechanisms and Therapy (12 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers). Huanwei Chen is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Cancer Mechanisms and Therapy (12 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers). Huanwei Chen collaborates with scholars based in China, Hong Kong and United States. Huanwei Chen's co-authors include Jieyuan Li, Rongdang Fu, Xiaohong Zhang, Wei Wei, Minshan Chen, Li Xu, Rong Guo, Yaojun Zhang, QiJiong Li and Yu-Jie Xu and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Huanwei Chen

33 papers receiving 617 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Huanwei Chen China	12	354	198	148	144	123	37	622
Yaqi Zhang China	14	161 0.5×	44 0.2×	103 0.7×	105 0.7×	158 1.3×	56	570
Oihane García‐Irigoyen Spain	15	295 0.8×	49 0.2×	243 1.6×	196 1.4×	455 3.7×	21	989
Silke Marhenke Germany	15	158 0.4×	143 0.7×	144 1.0×	111 0.8×	415 3.4×	22	806
Guangyu Ding China	12	129 0.4×	37 0.2×	169 1.1×	124 0.9×	240 2.0×	31	648
Akitoshi Douhara Japan	14	209 0.6×	152 0.8×	60 0.4×	125 0.9×	154 1.3×	25	653
Goro Kajiyama Japan	13	146 0.4×	82 0.4×	205 1.4×	365 2.5×	206 1.7×	32	800
Ting‐Fang Lee Taiwan	13	358 1.0×	25 0.1×	79 0.5×	124 0.9×	183 1.5×	21	707
Sen Han China	13	56 0.2×	174 0.9×	167 1.1×	44 0.3×	210 1.7×	39	620
Shigeki Takashima Japan	14	90 0.3×	44 0.2×	141 1.0×	234 1.6×	163 1.3×	62	620
Tracy L. Walling United States	9	153 0.4×	70 0.4×	54 0.4×	53 0.4×	210 1.7×	9	515

Countries citing papers authored by Huanwei Chen

Since Specialization

Citations

This map shows the geographic impact of Huanwei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huanwei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huanwei Chen more than expected).

Fields of papers citing papers by Huanwei Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huanwei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huanwei Chen. The network helps show where Huanwei Chen may publish in the future.

Co-authorship network of co-authors of Huanwei Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Huanwei Chen. A scholar is included among the top collaborators of Huanwei Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huanwei Chen. Huanwei Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tang, Shuang‐Yan, Yi Xiao, Feng Shi, et al.. (2025). Lenvatinib and tislelizumab versus atezolizumab and bevacizumab in combination with TAE-HAIC for unresectable hepatocellular carcinoma with high tumor burden: a multicenter retrospective cohort study. Cancer Immunology Immunotherapy. 74(3). 88–88. 1 indexed citations

Hu, Zili, Min Deng, Yizhen Fu, et al.. (2025). Neoadjuvant hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin for resectable single large hepatocellular carcinoma. International Journal of Surgery. 111(6). 3850–3858. 2 indexed citations

Tan, Xiaoyu, Zhiping Huang, Qing Ouyang, et al.. (2025). Six-hour local 4 °C dual hypothermic oxygenated machine perfusion improves the preservation of porcine liver after cardiac death using an ex vivo reperfusion model. Hepatobiliary & pancreatic diseases international. 24(3). 294–302.

Deng, Min, Chong Zhong, Dong Li, et al.. (2024). Hepatic arterial infusion chemotherapy-based conversion hepatectomy in responders versus nonresponders with hepatocellular carcinoma: a multicenter cohort study. International Journal of Surgery. 111(1). 135–145. 6 indexed citations

Cai, Mingyue, Licong Liang, Jian Zhang, et al.. (2024). Lenvatinib plus drug-eluting bead transarterial chemoembolization with/without hepatic arterial infusion chemotherapy for hepatocellular carcinoma larger than 7 cm with major portal vein tumor thrombosis: a multicenter retrospective cohort study. International Journal of Surgery. 110(12). 7860–7870. 9 indexed citations

Xu, Yuyan, et al.. (2024). Constructing diagnostic signature of serum microRNAs using machine learning for early pan-cancer detection. Discover Oncology. 15(1). 263–263. 1 indexed citations

Tang, Shuang‐Yan, Feng Shi, Zhiqiang Wu, et al.. (2024). TACE plus lenvatinib and tislelizumab for intermediate-stage hepatocellular carcinoma beyond up-to-11 criteria: a multicenter cohort study. Frontiers in Immunology. 15. 1430571–1430571. 5 indexed citations

Kuang, Ming, Lixia Xu, Mengping Zhang, et al.. (2024). Envafolimab combined with lenvatinib and gemcitabine plus cisplatin in advanced biliary tract cancer as first-line treatment: A single-arm, open-label, phase II study (ENLIGHTEN study).. Journal of Clinical Oncology. 42(16_suppl). e16188–e16188.

Chen, Song, Feng Shi, Zhiqiang Wu, et al.. (2023). Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab with or Without Transhepatic Arterial Embolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombus and High Tumor Burden: A Multicenter Retrospective Study. Journal of Hepatocellular Carcinoma. Volume 10. 1209–1222. 14 indexed citations

10.

Liu, Yuxi, et al.. (2023). Health-related quality of life and its influencing factors in patients with breast cancer based on the scale QLICP-BR. Scientific Reports. 13(1). 15176–15176. 7 indexed citations

11.

Li, Fei, Chonghua Wan, Zheng Yang, et al.. (2022). Development and Validation of the Breast Cancer Scale QLICP-BR V2.0 Based on Classical Test Theory and Generalizability Theory. Frontiers in Oncology. 12. 915103–915103. 5 indexed citations

12.

Li, Fei, et al.. (2022). Establishing Minimal Clinically Important Differences for the Quality of Life Instrument in Patients With Breast Cancer QLICP-BR (V2.0) Based on Anchor-Based and Distribution-Based Methods. Frontiers in Oncology. 12. 753729–753729. 7 indexed citations

13.

Chen, Song, Zhiqiang Wu, Feng Shi, et al.. (2021). Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially unresectable hepatocellular carcinoma harbouring PD-L1 expression: a retrospective study. Journal of Cancer Research and Clinical Oncology. 148(8). 2115–2125. 81 indexed citations

14.

Fu, Rongdang, et al.. (2020). Activation of the HGF/c-MET axis promotes lenvatinib resistance in hepatocellular carcinoma cells with high c-MET expression. Medical Oncology. 37(4). 24–24. 84 indexed citations

15.

Chen, Huanwei, Mon‐Yuan Yang, Tung‐Wei Hung, Yun‐Ching Chang, & Chau‐Jong Wang. (2019). Nelumbo nucifera leaves extract attenuate the pathological progression of diabetic nephropathy in high-fat diet-fed and streptozotocin-induced diabetic rats. Journal of Food and Drug Analysis. 27(3). 736–748. 48 indexed citations

16.

Javle, Milind, Fei Pang, Zhao Wei, et al.. (2019). Somatic genetic aberrations in gallbladder cancer: comparison between Chinese and US patients. HepatoBiliary Surgery and Nutrition. 8(6). 604–614. 36 indexed citations

17.

Lei, Qiucheng, Jingcheng Bi, Huanwei Chen, et al.. (2017). Glucagon-like peptide-2 improves intestinal immune function and diminishes bacterial translocation in a mouse model of parenteral nutrition. Nutrition Research. 49. 56–66. 12 indexed citations

18.

Xiang, Qingfeng, Zuojun Zhen, David Deng, et al.. (2015). Tivantinib induces G2/M arrest and apoptosis by disrupting tubulin polymerization in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 34(1). 118–118. 33 indexed citations

19.

Chen, Huanwei, et al.. (2014). Prognostic impact of hepatic resection for hepatocellular carcinoma: The role of the surgeon in achieving R0 resection – A retrospective cohort study. International Journal of Surgery. 13. 297–301. 13 indexed citations

20.

Zhang, Jingliang, Zhongming Huang, Hang Li, et al.. (2008). A new surgery treatment for thumb reconstruction by one-stage plasty free second toe transfer. 31(5). 335–337. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact